Ovarian Cancer

In the Basser Center's Annual Research Webinar, Executive Director Susan Domchek, MD, covers the latest updates in hereditary cancer care, BRCA research, and genetics, addressing advances in 2020 and exploring options for the future.

Basser Center Executive Director Susan Domchek, MD, answers a series of frequently asked questions. She discusses ovarian cancer surveillance, BRCA mutations in the Ashkenazi Jewish community, COVID vaccines, and more.

Basser Director of Gynecologic Research, Ronny Drapkin, MD, PhD, discusses the cellular origins of ovarian cancer in the fallopian tubes.

Basser Director of Gynecologic Cancer Research, Ronny Drapkin, MD, PhD, discusses the relationship between ovarian cancer and the fallopian tubes and highlights the importance of BRCA-related cancer research.

The Basser Center’s virtual Breakthroughs and Discoveries panel brought together internationally renowned experts in the field of BRCA-related cancer research and care to discuss how discoveries in the lab translate to patient care.

Basser Young Leadership Council co-chair and patient advocate Erika Stallings discusses racial disparities in hereditary cancer, BRCA mutations in the Black community, and more with Basser Center scientist and Penn Medicine medical oncologist Payal Shah, MD.

In this ongoing series of answers to common questions received by the Basser Center, Executive Director Susan Domchek, MD, discusses recent advancements in treatment options for BRCA-related cancers, such as drugs like PARP inhibitors.

Basser Executive Director Susan Domchek, MD, discusses BRCA-related ovarian cancer risk and management options, such as recent research into fallopian tube removal.